Personal information

Activities

Collapse all

Employment (3)

Fondren Orthopedic Group LLP: Houston, TX, US

2023-11-21 to present | Jr. Clinical Data Scientist (Fondren Orthopedic Research Institute)
Employment
Source: Self-asserted source
Allyson N Pfeil

Fondren Orthopedic Group LLP: Houston, TX, US

2022-11-21 to 2023-11-21 | Research Associate III (Fondren Orthopedic Research Institute)
Employment
Source: Self-asserted source
Allyson N Pfeil

The University of Texas MD Anderson Cancer Center: Houston, Texas, US

2021-07-12 to 2022-11-17 | Research Assistant 1 (Thoracic Head and Neck Medical Oncology Research)
Employment
Source: Self-asserted source
Allyson N Pfeil

Education and qualifications (1)

University of South Florida: Tampa, Florida, US

2017-08-14 to 2020-05 | Bachelor of Science/Biomedical Sciences (Chemistry)
Education
Source: Self-asserted source
Allyson N Pfeil

Professional activities (1)

Orthopaedic Research Society: Rosemont, Illinois, US

2023-01-01 to 2024-12-31 | Affiliate Member
Membership
Source: Self-asserted source
Allyson N Pfeil

Works (6)

Rate of Reimbursement for 22-Modifier in Shoulder Surgery

JSES Reviews, Reports, and Techniques
2025-01 | Journal article
DOI: 10.1016/j.xrrt.2024.12.007
Contributors: Walter Smith; Allyson N. Pfeil; Matthew A. Coker; Pito Huerta; Davin K. Fertitta; Corey F. Hryc; T. Bradley Edwards; Michael C. Cusick
Source: check_circle
Crossref

Arthroscopic Debridement After Total Knee Arthroplasty Is More Effective for Synovitis Than for Ankylosis

Arthroscopy, Sports Medicine, and Rehabilitation
2024-10 | Journal article
DOI: 10.1016/j.asmr.2024.100965
Contributors: Hussein Elkousy; Davin K. Fertitta; Laith Elkousy; Maudood Rana; Allyson N. Pfeil; Corey F. Hryc
Source: check_circle
Crossref

The 22-Modifier in Total Hip and Knee Arthroplasty: A Comprehensive Analysis

The Journal of Arthroplasty
2024-07 | Journal article
DOI: 10.1016/j.arth.2024.01.046
Contributors: Robert Comrie; Allyson N. Pfeil; Pito Huerta; Kurt Lautenshlager; Corey F. Hryc; Ugonna N. Ihekweazu
Source: check_circle
Crossref

Orthopedic Hardware Type Impacts Case Complexity in Conversion Total Hip Arthroplasty Surgery

Arthroplasty Today
2024-04 | Journal article
DOI: 10.1016/j.artd.2024.101317
Contributors: Justin Cardenas; Allyson N. Pfeil; Davin K. Fertitta; Robert Comrie; Delia Rospigliosi; Mariya Shumareva; Emily Vidal; Corey F. Hryc; Ugonna N. Ihekweazu
Source: check_circle
Crossref

P2.09-30 Enhanced in Vivo Efficacy of Mobocertinib and Amivantamab Combination in EGFR ex20ins+ NSCLC PDX Models

Journal of Thoracic Oncology
2023-11 | Journal article
DOI: 10.1016/j.jtho.2023.09.603
Part of ISSN: 1556-0864
Contributors: S. Chatterjee; X. Le; M. Nilsson; M. Smith; A. Barakat; I. Celen; E.N. Churchill; H. Udagawa; A. Poteete; A.N. Pfeil et al.
Source: Self-asserted source
Allyson N Pfeil

CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance

Cancer Cell
2023-02 | Journal article
DOI: 10.1016/j.ccell.2023.01.007
Part of ISSN: 1535-6108
Contributors: Monique B. Nilsson; Yan Yang; Simon Heeke; Sonia A. Patel; Alissa Poteete; Hibiki Udagawa; Yasir Y. Elamin; Cesar A. Moran; Yukie Kashima; Thiruvengadam Arumugam et al.
Source: Self-asserted source
Allyson N Pfeil
How many people are using ORCID?